Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 34,13 € (+25,34 %). La médiane est de 32,83 € (+20,57 %).
| Acheter |
4 |
| Conserver |
8 |
| Vendre |
1 |
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
Oscar Health hits 52-week high at $34.09
Oscar Health’s stock rose to a 52-week high of $34.09 and is currently trading at $33.81. Over the past year the stock gained 68.55%; in the last six months it rose 143% and year-to-date it is up 127%. In the second quarter Oscar Health beat expectations with adjusted earnings of $1.10 per share (expectation $0.37) and revenue of $4.88 billion (expectation $4.73 billion). Analysts currently view the stock as overvalued, according to InvestingPro, and there was a premarket price decline despite the strong quarterly results. » Plus sur de.investing.com
Oscar Health reaches 52-week high at $33.12
Oscar Health’s stock climbed to a 52-week high of $33.12 and has a market capitalization of $10.17 billion and a P/E ratio of 17.27. Year-to-date the share price is up 110.1%, up 114% since the start of the year, and up 129% over six months. In the second quarter Oscar Health beat expectations with adjusted earnings per share of $1.10 and revenue of $4.88 billion; the company attributes the results to record profitability, improved medical cost trends and tighter cost control. An analysis by InvestingPro currently rates the stock as overvalued. » Plus sur de.investing.com
Oscar Health raises 2026 operating earnings guidance after record first-half profitability
Oscar Health reported $1 billion net income in the first half of 2026, citing disciplined pricing, operating leverage and AI tools (Oswell) that guided members to lower-cost care and identified pharmacy savings. Management raised full-year 2026 earnings from operations guidance to $500 million–$700 million and expects full-year MLR of 81.5%–82.5%, while forecasting higher churn in H2 as CMS eligibility verifications accelerate. Company noted a $160 million favorable 2025 risk-adjustment true-up, continued SG&A efficiency from its single-platform tech stack, and ongoing CMS reviews with anticipated impacts already reflected in guidance. » Plus sur finance.yahoo.com
Oscar Health posts $361 million Q2 profit as membership and revenues surge
Oscar Health reported a $361.8 million second-quarter profit and $1.04 billion in net income for the first half of 2026, driven by revenue growth to $4.9 billion and an increase in health plan members to 2.9 million. The company credited disciplined pricing, scalable technology and $164 million of favorable prior-period reserve development for a lower medical loss ratio of 79.2%, down from 91.1% year over year. CEO Mark Bertolini said Oscar is positioned for continued profitable growth in the Affordable Care Act individual market and raised its full-year outlook on several metrics. » Plus sur forbes.com
Oscar Health relies on app and AI assistant and grows to 3.2 million members
According to a report, Oscar Health has 3.2 million members and saw rising membership in the first quarter. The company is focusing on digital healthcare via an app and an AI assistant, which has generated increased investor interest. Oscar currently covers about 20 states and is viewed as a growth company; its stock was up roughly 36% over the reporting period. » Plus sur finanzen.net
Données financières de l'entreprise
| (EUR) | septembre 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 4,54 Md | 78,32 % |
| Bénéfice brut | 800,26 M | 134,99 % |
| Bénéfice net | 147,7 M | 226,11 % |
| EBITDA | 164,78 M | 254,55 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 7,41 Md € |
Nombre d'actions | 259,27 M |
Plus haut/bas sur 52 semaines | 35,11 € - 9,75 € |
| Dividendes | Non |
Bêta | 2,49 |
Ratio P/E | 11,27 |
Ratio PEG | 0,02 |
Ratio P/B | 4,36 |
Ratio P/S | 0,46 |
Profil de l'entreprise
Oscar Health, Inc. propose des produits et services d'assurance santé aux États-Unis. La société offre des plans Individuel et Famille, Petite Entreprise et Medicare Advantage, ainsi que +Oscar, une plateforme technologique conçue pour aider les prestataires de soins et les clients payeurs à interagir avec leurs membres et patients. Elle fournit également des produits de réassurance. La société était auparavant connue sous le nom de Mulberry Health Inc. et a changé sa dénomination en Oscar Health, Inc. en janvier 2021. Oscar Health, Inc. a été constituée en 2012 et son siège social se trouve à New York, New York.
| Nom | Oscar Health |
| PDG | Mark Thomas Bertolini |
| Siège social | New York City,
ny États-Unis |
| Site web | |
| Secteur | Santé |
| Industrie | Prestataires et services de santé |
| Introduction en bourse | 03/03/2021 |
| Employés | 2 305 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NYSE | OSCR |